evidencegaps
Primary study · included by 1 review

Study on the efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy regimen for III-IVA esophageal squamous cell carcinoma post-surgery.

Li 2024 · Li Chunyang, Yu Pengyi, Li Hong, et al. · Journal of cardiothoracic surgery · 2024

Included by

The Efficacy and Safety of Neoadjuvant Immunotherapy in Pan-Squamous Cell Carcinomas: A Meta-Analysis of Esophageal, Head and Neck, Cervical, Lung, Cutaneous, and Oral Squamous Cell Carcinomas.
Non-Cochrane · intervention · 2026 · cited as Li 2024 · Supplementary Table S1; reference list

The review does not say which of its outcomes this study informs.

1 including review in total.